Polymerase Chain Reaction Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Polymerase Chain Reaction Market: By Product (Instruments, Reagents and Consumables, and Software), Application (Clinical Diagnostics, Life Science Research, Industrial Applications, and Others), End User (Academic Institutes, Clinical Diagnostics Labs and Hospitals, Pharmaceutical and Biotechnology Industries, and Others), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Polymerase Chain Reaction Market size is expected to be worth USD 36,090.3million in 2022, growing at a high CAGR of 5.3% from 2022 to 2028 to reach USD 49,199.5 million by 2028. The polymerase chain reaction (PCR) is a technique for amplifying DNA sequences in the lab. The process includes selecting the part of the genome to be amplified using short DNA sequences called primers. To aid a DNA replication enzyme in copying the target DNA sequence, the temperature of the sample is increased and dropped repeatedly. In just a few hours, the process can manufacture a billion duplicates of the target sequence. In 2021, instruments had a market revenue share of 27.2%, and from 2022 to 2028, it is predicted to increase at a CAGR of 5.7%. PCR plays a critical role in the treatment of patients with COVID-19. Clinical diagnostics labs have a market share of 45.7% by end-user segment and are expected to increase at a CAGR of xx % in the future years. Increased application in clinical diagnostics, increased demand for customised and precision medicine, and technological breakthroughs and applications in drug development are driving the Polymerase Chain Reaction market. Increasing demand for personalised and precision medicine has resulted in a paradigm shift in drug discovery, personalised medicine, forensic sciences, and clinical research and development in the biotechnology industry, due to technological advancements in molecular biology, life sciences, and biotechnology. However, the emergence of alternative technologies and the high cost of instruments hamper the Polymerase Chain Reaction market.

Key Developments:

In June 2021, Thermo Fisher Scientific Inc. launched TaqPath, a new CE-IVD-marked fast PCR combo kit 2.0 to detect active SARS-CoV-2 infection.

Polymerase Chain Reaction Market

MARKET SUMMARY
-
5.3%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 5.3%
  • Largest Market– Asia Pacific
  • Fastest Growing Market–  North America

Polymerase Chain Reaction Market

  • The polymerase chain reaction market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • The polymerase chain reaction market is segmented based on based on product, application, end-user, and geography.
Key Players
  • Abbott
  • Qiagen
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Hoffmann-La Roche Ltd
Polymerase Chain Reaction Market Dynamics

Polymerase Chain Reaction market is surging owing to frequent acquisitions and launchings by the market players. Strategic alliances by the players such as acquisitions, mergers, expansions and new product launches may enhance the company’s growth. In In April 2020, Promega’s Corporation’s GoTaqProbe 1-Step RT-qPCR System is approved by Centers for Disease Control and Prevention COVID-19 diagnostic protocol for emergency use.


North-America Got Significant Share

Polymerase Chain Reaction Market

North America is predicted to have the largest share of the Polymerase Chain Reaction market by 2028, and it is expected to grow at a rapid pace in the following years. The increasing prevalence of hereditary and chronic illnesses, such as cancer, the ageing population, the increased need for precision and customized care, and favorable government initiatives drive the market in the region.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The polymerase chain reaction market report provides granular level information about the market size, regional market share, historic market (2017-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Polymerase Chain Reaction Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The polymerase chain reaction market is projected to expand at a CAGR of 5.3% during the forecast period.

Abbott, Qiagen, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., bioMérieux SA, Hoffmann-La Roche Ltd

North America is dominating the polymerase chain reaction market


Report

Company Profile

  • Abbott
  • Qiagen
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Hoffmann-La Roche Ltd
  • Agilent Technologies, Inc.
  • Fluidigm Corporation
  • Cytiva
  • Stilla Technologies
  • Microsynth AG
  • JN Medsys
  • Danaher Corporation

Description

Polymerase Chain Reaction Market size is expected to be worth USD 36,090.3million in 2022, growing at a high CAGR of 5.3% from 2022 to 2028 to reach USD 49,199.5 million by 2028. The polymerase chain reaction (PCR) is a technique for amplifying DNA sequences in the lab. The process includes selecting the part of the genome to be amplified using short DNA sequences called primers. To aid a DNA replication enzyme in copying the target DNA sequence, the temperature of the sample is increased and dropped repeatedly. In just a few hours, the process can manufacture a billion duplicates of the target sequence. In 2021, instruments had a market revenue share of 27.2%, and from 2022 to 2028, it is predicted to increase at a CAGR of 5.7%. PCR plays a critical role in the treatment of patients with COVID-19. Clinical diagnostics labs have a market share of 45.7% by end-user segment and are expected to increase at a CAGR of xx % in the future years. Increased application in clinical diagnostics, increased demand for customised and precision medicine, and technological breakthroughs and applications in drug development are driving the Polymerase Chain Reaction market. Increasing demand for personalised and precision medicine has resulted in a paradigm shift in drug discovery, personalised medicine, forensic sciences, and clinical research and development in the biotechnology industry, due to technological advancements in molecular biology, life sciences, and biotechnology. However, the emergence of alternative technologies and the high cost of instruments hamper the Polymerase Chain Reaction market.

Key Developments:

In June 2021, Thermo Fisher Scientific Inc. launched TaqPath, a new CE-IVD-marked fast PCR combo kit 2.0 to detect active SARS-CoV-2 infection.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX